HMGB1 and Hyperglycemia: Quantitative analysis demonstrated that iHMGB1 KO TMX STZ mice had significantly lower hyperglycemia compared to HMGB1 Flox TMX STZ mice, with a reduction of 33.99 % (p = 0.0038) eight weeks into the hyperglycemia phenotype development (Fig. 3D).